Text
The product, based on the pioneering research of Dr. Jacques Ravel, is the first of its kind to be clinically validated for establishing an optimal vaginal microbiome, dominated by Lactobacillus…
Industry
Sponsored by
The company was honored with the Ingredient of the Year award in the Microbiome Modulation and the Beauty from Within category.
The findings of a recent study highlight the importance of considering age-related immune changes and gut microbiota composition for developing personalized immunotherapy approaches.
A recent study demonstrated causation between microbial DCA metabolism and anti-tumor CD8+ T cell response in colorectal cancer.
Bi104 is a microbiome-modifying biologic designed to diversify and modulate the gut microflora and metabolite profile.
The findings of a recent study shed light on how the microbiota impacts cholesterol levels. They may also inform microbial-based interventions against high cholesterol.
Industry
Sponsored by
Join SynBalance at Vitafoods Europe 2024, held at Palexpo, Switzerland from May 14th to May 16th.
The findings of a recent study suggest that L. johnsonii or its metabolite IPA could be used as a microbial-based approach to improve a person’s response to immunotherapy.
The intersection of gaming and science has birthed an innovative approach to scientific research and public engagement.
This unprecedented partnership signifies a concerted effort to address pressing microbiome-related challenges and advance health equity worldwide.
